We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
In this week’s blog, Dr. Durie makes sense of the CDC’s new COVID-19 guidelines by elaborating on the implications of recommendations vs mandates, by adapting new COVID-19 guidance specifically for myeloma patients, and by emphasizing the need for continued prudence to avoid being infected with COVID-19. READ THE BLOG.
The 2023 Brian D. Novis Research Grants are now accepting applications. BDN Grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. Deadline for submission is September 1, 2022. APPLY NOW.
The IMF Patient & Family Webinar (PFS) – Back to Basics: From Testing to Tailored Therapy will be held on Saturday, August 20 at 10 a.m. PST/11 a.m. MST/12 p.m. CT/ 1 p.m. ET. Topics to be discussed include Recommended Testing and Monitoring: 2022 Algorithms, Frontline Options, Managing Myeloma Care, and Relapse Options: FDA Approved/Clinical Trials. REGISTER NOW.
Blenrep® (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the combination of a monoclonal antibody (mAb) that binds to a specific receptor on the surface of myeloma cells called B-cell maturation antigen (BCMA), coupled with monomethyl auristatin F (MMAF), a drug that can kill myeloma cells. DOWNLOAD NOW.
The 4th Annual Inland Empire/Virtual/In Person Walk for Myeloma Miracles will be held on Saturday, September 24, 9:00 a.m. PST at Central Park in Rancho Cucamonga, CA. Register as a participant or a team member, donate to a participant or a team, or purchase a Remembrance Path. Donations will also be accepted on the day of the event. REGISTER NOW.
Our hearts go to all innocent victims of the ongoing conflict in Ukraine.
As a global organization, the International Myeloma Foundation supports — and will continue to support — every myeloma patient, caregiver, doctor, researcher, and advocate going through struggles and difficulties brought about by the war in Ukraine.
As an advocate for hope and resilience among the members of the myeloma community, the IMF is here for you — and even to a greater degree, during this most difficult time.
Our mission is clear, and our steadfast commitment continues — to improve the quality of life of myeloma patients across the globe, while working toward prevention and a cure.
Need assistance in creating a fundraiser? The IMF team is here for you. Find out how you can help in the fight against myeloma today!